Last reviewed · How we verify

Silymarine supplementation — Competitive Intelligence Brief

Silymarine supplementation (Silymarine supplementation) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal supplement / Hepatoprotective agent. Area: Hepatology / Gastroenterology.

phase 3 Herbal supplement / Hepatoprotective agent Hepatology / Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Silymarine supplementation (Silymarine supplementation) — University Hospital, Martin. Silymarin is a flavonolignan extract from milk thistle that acts as a hepatoprotective agent by reducing oxidative stress and supporting liver cell regeneration.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Silymarine supplementation TARGET Silymarine supplementation University Hospital, Martin phase 3 Herbal supplement / Hepatoprotective agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal supplement / Hepatoprotective agent class)

  1. University Hospital, Martin · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Silymarine supplementation — Competitive Intelligence Brief. https://druglandscape.com/ci/silymarine-supplementation. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: